Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novartis researchers describe beta2-adrenergic agonists

Dec. 1, 2004

Ono claims elastase inhibitors for COPD, pulmonary emphysema, rheumatoid arthritis, etc.

Nov. 25, 2004

Results of phase I study of FG-3019 in idiopathic pulmonary fibrosis

Nov. 24, 2004

Study of interferon gamma-1b in idiopathic pulmonary fibrosis continues

Nov. 24, 2004

CAT and AstraZeneca form alliance in inflammatory disorders

Nov. 24, 2004

Novel method for treatment for neutrophil-mediated conditions

Nov. 24, 2004

Dual acting piperidine derivatives claimed by AstraZeneca

Nov. 23, 2004

Phase I studies completed for aerosolized hydroxychloroquine

Nov. 23, 2004

Approval for Atrovent HFA

Nov. 23, 2004

Researchers at Bayer describe new CCR3 antagonists

Nov. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...